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INTRODUCTION: 
 
 
The word sepsis originated from the old Greek word meaning “putrefaction”. 
Nowadays, this term is used to describe the host systemic response to infectious 
stimuli that is characterised by clinical, haemodynamic, biochemical and 
inflammatory responses1 . Sepsis is still one of the leading causes of death in the 
critically ill patients2.  
 
In daily practice, clinicians are often faced with two dilemmas: 1.whether a 
patient is infected or not, and 2.whether the antibiotic therapy being given is 
effective. The distinction between infection and sepsis is frequently difficult to 
make. Infection without sepsis can occur if the process remains localised. A 
sepsis-like syndrome without infection is also a frequent finding in conditions 
such as trauma and pancreatitis3. 
 
The attention of the clinician must be directed towards the early diagnosis of 
infection4 . However, bacteriological confirmation may be difficult to obtain 
and negative cultures do not exclude the presence of infection. In addition, 
manifestations of sepsis such as fever, leukocytosis and tachycardia are neither 
specific nor sensitive for infection, nor for monitoring the response to therapy 5 . 
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Increasing understanding of the various inflammatory cascade mechanisms has 
given new insights and provided several markers that, in conjunction with other 
manifestations of sepsis, can be useful as indicators of infection. C-reactive 
protein (CRP) is one such marker. 
 
 
A marker of sepsis has been defined as “a measure that identifies a normal 
biologic state or that predicts the presence or severity of a pathologic process 
or disease.”7 
 
 
CRP levels are widely used as a relatively non-specific marker of inflammation. 
Many studies have demonstrated increased CRP levels in patients with sepsis; 
increasing or persistently high levels suggest a poor prognosis, while declining 
values are associated with a more favourable prognosis.  
 
 
Elevated serum levels of the intracellular enzyme LDH in sepsis might result 
from various mechanisms including cellular injury related to bacterial toxins, 
ischemia and cytotoxic-reactive oxygen species generated during reperfusion. 
Various studies have confirmed the presence of elevated LDH levels in severe 
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sepsis. There is a study in US which predicted the development of ARDS in 
patients in sepsis based on serum LDH levels8. 
 
 
In the present study, serum LDH and CRP concentrations in all patients 
admitted to the emergency ward with clinical sepsis were measured and 
compared  their prognostic value in the assessment of severity and 
mortality. 
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AIMS AND OBJECTIVES  
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AIMS AND OBJECTIVES:  
 
 
 
1. To analyse the relationship of LDH and CRP levels on admission  to 
APACHE-II score in patients with sepsis. 
 
2. To determine whether LDH and CRP levels can predict morbidity and 
mortality in patients with sepsis . 
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REVIEW OF LITERATURE: 
Definitions 
Animals mount both local and systemic responses to microbes that traverse their 
epithelial barriers and enter underlying tissues. Fever or hypothermia, 
leukocytosis or leukopenia, tachypnea, and tachycardia are the cardinal signs of 
the systemic response that is often called the systemic inflammatory response 
syndrome (SIRS). SIRS may have an infectious or a non-infectious etiology. If 
infection is suspected or proven, a patient with SIRS is said to have sepsis. 
When sepsis is associated with dysfunction of organs distant from the site of 
infection, the patient has severe sepsis. Severe sepsis may be accompanied by 
hypotension or evidence of hypoperfusion. When hypotension cannot be 
corrected by infusing fluids, the diagnosis is septic shock. These definitions 
were developed by consensus conference committees in 1992 and 2001 and 
have been widely used; there is evidence that the different stages may form a 
continuum. 
Bacteremia - Presence of bacteria in blood, as evidenced by positive blood 
cultures 
Septicemia - Presence of microbes or their toxins in blood 
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Systemic inflammatory response syndrome (SIRS) 
Two or more of the following conditions: 
1. fever (oral temperature >38°C) or hypothermia (<36°C);  
2. tachypnea (>24 breaths/min);  
3. tachycardia (heart rate >90 beats/min);  
4. leukocytosis (>12,000/microL), leukopenia (<4,000/microL), or >10% 
bands; may have a non-infectious etiology 
Sepsis - SIRS that has a proven or suspected microbial etiology 
 
Severe sepsis (similar to "sepsis syndrome") 
Sepsis with one or more signs of organ dysfunction—for example: 
1. Cardiovascular: Arterial systolic blood pressure <90 mmHg or mean 
arterial pressure<70 mmHg that responds to administration of intravenous 
fluid 
2. Renal: Urine output <0.5 mL/kg per hour for 1 hour despite adequate 
fluid resuscitation 
3. Respiratory: PaO2/FIO2 <=250 or, if the lung is the only dysfunctional 
organ, <=200 
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4. Hematologic: Platelet count <80,000/microL or 50% decrease in platelet 
count from highest value recorded over previous 3 days 
5. Unexplained metabolic acidosis: A pH <=7.30 or a base deficit >=5.0 
mEq/L and a plasma lactate level >1.5 times upper limit of normal for 
reporting lab 
6. Adequate fluid resuscitation: Pulmonary artery wedge pressure >=12 
mmHg or central venous pressure >=8 mmHg 
 
Septic shock  
Sepsis with hypotension (arterial blood pressure <90 mmHg systolic, or 40 
mmHg less than patient's normal blood pressure) for at least 1 hour despite 
adequate fluid resuscitation; 
Or 
Need for vasopressors to maintain systolic blood pressure >=90 mmHg or mean 
arterial pressure >=70 mmHg 
 
Refractory septic shock  
 Septic shock that lasts for >1 hour and does not respond to fluid or pressor 
administration 
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Multiple-organ dysfunction syndrome (MODS)  
 Dysfunction of more than one organ, requiring intervention to maintain 
homeostasis 
 
Etiology: 
Sepsis can be a response to any class of microorganism. Microbial invasion of 
the bloodstream is not essential, since local inflammation can also elicit distant 
organ dysfunction and hypotension. In fact, blood cultures yield bacteria or 
fungi in only 20–40% of cases of severe sepsis and 40–70% of cases of septic 
shock. Individual gram-negative or gram-positive bacteria account for 70% of 
these isolates; the remainder are fungi or a mixture of microorganisms. 
 
Pathophysiology 
Most cases of severe sepsis are triggered by bacteria or fungi that do not 
ordinarily cause systemic disease in immunocompetent hosts . To survive 
within the human body, these microbes often exploit deficiencies in host 
defenses, indwelling catheters or other foreign matter, or obstructed fluid 
drainage conduits. 
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 Microbial pathogens, in contrast, can circumvent innate defenses because they 
(1) lack molecules that can be recognized by host receptors or (2) elaborate 
toxins or other virulence factors. In both cases, the body can mount a vigorous 
inflammatory reaction that results in severe sepsis yet fails to kill the invaders. 
The septic response may also be induced by microbial exotoxins that act as 
superantigens (e.g., toxic shock syndrome toxin ) as well as by many pathogenic 
viruses. 
 
Local and Systemic Host Responses to Invading Microbes 
Recognition of microbial molecules by tissue phagocytes triggers the 
production and/or release of numerous host molecules (cytokines, chemokines, 
prostanoids, leukotrienes, and others) that increase blood flow to the infected 
tissue, enhance the permeability of local blood vessels, recruit neutrophils to the 
site of infection, and elicit pain. These reactions are familiar elements of local 
inflammation, the body's frontline innate immune mechanism for eliminating 
microbial invaders. Systemic responses are activated by neural and/or humoral 
communication with the hypothalamus and brainstem; these responses enhance 
local defenses by increasing blood flow to the infected area, augmenting the 
number of circulating neutrophils, and elevating blood levels of numerous 
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molecules (such as the microbial recognition proteins discussed above) that 
have anti-infective functions. 
Cytokines and Other Mediators 
Cytokines can exert endocrine, paracrine, and autocrine effects . TNF-alpha 
stimulates leukocytes and vascular endothelial cells to release other cytokines  
to express cell-surface molecules that enhance neutrophil-endothelial adhesion 
at sites of infection, and to increase prostaglandin and leukotriene production. 
Although TNF-alpha is a central mediator, it is only one of many 
proinflammatory molecules that contribute to innate host defense. Chemokines, 
most prominently interleukin (IL)-8 and IL-17, attract circulating neutrophils to 
the infection site. IL-1beta  exhibits many of the same activities as TNF-alpha. 
IFN gamma, IL-12, IL-17, and other proinflammatory cytokines probably 
interact synergistically with one another and with additional mediators. The 
nonlinearity and multiplicity of these interactions have made it difficult to 
interpret the roles played by individual mediators in both tissues and blood. 
Coagulation Factors 
Intravascular thrombosis, a hallmark of the local inflammatory response, may 
help wall off invading microbes and prevent infection and inflammation from 
spreading to other tissues. IL-6 and other mediators promote intravascular 
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coagulation initially by inducing blood monocytes and vascular endothelial cells 
to express tissue factor  
CONTROL MECHANISMS 
1. Local Control Mechanisms 
The anti-inflammatory forces that put out the fire and clean up the battleground 
include molecules that neutralize or inactivate microbial signals. Among these 
molecules are intracellular factors (e.g., suppressor of cytokine signalling 3 and 
IL-1 receptor–associated kinase 3) that diminish the production of 
proinflammatory mediators by neutrophils and macrophages; anti-inflammatory 
cytokines (IL-10, IL-4); and molecules derived from essential polyunsaturated 
fatty acids (lipoxins, resolvins, and protectins) that promote tissue restoration. 
2. Systemic Control Mechanisms 
Systemic responses to infection  diminish the cellular responses to microbial 
molecules. Circulating levels of anti-inflammatory cytokines (e.g., IL-10) 
increase even in patients with mild infections. Glucocorticoids inhibit cytokine 
synthesis by monocytes in vitro; the increase in blood cortisol levels early in the 
systemic response presumably plays a similarly inhibitory role. Epinephrine 
inhibits the TNF-alpha  response to endotoxin infusion in humans while 
augmenting and accelerating the release of IL-10; prostaglandin E2 has a 
similar "reprogramming" effect on the responses of circulating monocytes to 
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LPS and other bacterial agonists. Cortisol, epinephrine, IL-10, and C-reactive 
protein reduce the ability of neutrophils to attach to vascular endothelium, 
favouring their demargination and thus contributing to leukocytosis while 
preventing neutrophil-endothelial adhesion in uninflamed organs. 
It can thus be concluded that both local and systemic responses to infectious 
agents benefit the host in important ways. Most of these responses and the 
molecules responsible for them have been highly conserved during animal 
evolution and therefore may be adaptive. Elucidating how they contribute to 
lethality—i.e., become maladaptive—remains a major challenge for sepsis 
research. 
Organ Dysfunction and Shock 
As the body's responses to infection intensify, the mixture of circulating 
cytokines and other molecules becomes very complex: elevated blood levels of 
more than 50 molecules have been found in patients with septic shock. 
Although high concentrations of both pro- and anti-inflammatory molecules are 
found, the net mediator balance in the plasma of these extremely sick patients 
seems to be anti-inflammatory. 
Endothelial Injury 
Many investigators have favoured widespread vascular endothelial injury as the 
major mechanism for multiorgan dysfunction. 
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Septic Shock 
The hallmark of septic shock is a decrease in peripheral vascular resistance that 
occurs despite increased levels of vasopressor catecholamines. Prominent 
hypotensive molecules include nitric oxide, beta-endorphin, bradykinin, 
platelet-activating factor, and prostacyclin. 
The pathogenesis of severe sepsis may differ according to the infecting microbe, 
the ability of the host's innate defense mechanisms to sense it, the site of the 
primary infection, the presence or absence of immune defects, and the prior 
physiologic status of the host. 
Clinical Manifestations 
The manifestations of the septic response are superimposed on the symptoms 
and signs of the patient's underlying illness and primary infection. The rate at 
which severe sepsis develops may differ from patient to patient, and there are 
striking individual variations in presentation. 
Major Complications 
1. Cardiopulmonary Complications 
Ventilation-perfusion mismatching produces a fall in arterial PO2 early in the 
course. Progressive  diffuse pulmonary infiltrates and arterial hypoxemia 
(PaO2/FIO2, <300) indicate the development of acute lung injury; more severe 
17 
 
hypoxemia (PaO2/FIO2, <200) denotes the acute respiratory distress syndrome 
(ARDS). 
Sepsis-induced hypotension (see "Septic Shock," above) usually results initially 
from a generalized maldistribution of blood flow and blood volume and from 
hypovolemia that is due, at least in part, to diffuse capillary leakage of 
intravascular fluid. 
Depression of myocardial function, manifested as increased end-diastolic and 
systolic ventricular volumes with a decreased ejection fraction, develops within 
24 hours in most patients with severe sepsis. 
2. Renal Complications 
Oliguria, azotemia, proteinuria, and non-specific urinary casts are frequently 
found. Many patients are inappropriately polyuric; hyperglycemia may 
exacerbate this tendency. Most renal failure is due to acute tubular necrosis 
induced by hypotension or capillary injury. 
3. Coagulopathy 
Although thrombocytopenia occurs in 10–30% of patients, the underlying 
mechanisms are not understood. Platelet counts are usually very low 
(<50,000/microL) in patients with DIC. 
 
18 
 
4. Neurologic Complications 
When the septic illness lasts for weeks or months, "critical illness" 
polyneuropathy may prevent weaning from ventilatory support and produce 
distal motor weakness. Electrophysiological studies are diagnostic. Guillain-
Barre syndrome, metabolic disturbances, and toxin activity must be ruled out. 
5. Immunosuppression 
Patients with severe sepsis are often profoundly immunosuppressed. 
Manifestations include loss of delayed-type hypersensitivity reactions to 
common antigens, failure to control the primary infection, and increased risk for 
secondary infections (e.g., by opportunists such as Stenotrophomonas 
maltophilia, Acinetobacter calcoaceticus-baumannii, and Candida albicans)8. 
Increasing understanding of the various inflammatory cascade mechanisms has 
given new insights and provided several markers that, in conjunction with other 
manifestations of sepsis, can be useful as indicators of infection. C-reactive 
protein (CRP) is one such marker. 
C-REACTIVE PROTEIN 
 
Physiology of C-reactive protein 
C-reactive protein is a long-established marker of sepsis. In 1930, Tillet and 
Francis identified, in the sera of patients with pneumonia, the capacity to 
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precipitate polysaccharide fractions, designated as fraction C, from 
Streptococcus pneumoniae9. This property quickly disappeared as patients 
recovered and was not identified in healthy volunteers. When the cause of this 
reaction was identified as a protein, it was named CRP. The “acute phase” 
designation was introduced to classify acutely ill patients with infection whose 
sera was CRP positive. Since then, several other acute phase proteins have been 
described. 
 
C-reactive protein belongs to the pentraxin family of proteins, so called because 
they form a cyclic pentamer composed of five identical non-glycosylated sub-
units. C-reactive protein binds to several polysaccharides and peptido-
polysaccharides present in bacteria, fungi and parasites in the presence of 
calcium. These complexes activate the classical complement pathway, acting as 
opsonins and promoting phagocytosis10. Together with complement 
components, CRP is the only acute phase protein directly involved in the 
clearance of micro-organisms. 
 
The serum concentration of CRP in the normal human population has a median 
of 0.8 mg/l (interquartile range 0.3–1.7 mg/l) and is below 10 mg/l in 99% of 
normal samples11,12. Levels above these values are abnormal and indicate the 
presence of a disease process. 
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 As with many other acute phase proteins, CRP is predominantly synthesised by 
the liver, mainly in response to interleukin 6 (IL-6) . A good correlation exists 
between CRP and IL-6 levels 13. Tumour necrosis factorα (TNFα) and IL-1 are 
also regulatory mediators of CRP synthesis . The secretion of CRP begins 
within 4–6 h of the stimulus, doubling every 8 h and peaking at 36–50 h. 
 
Elevations in serum CRP are seen with most invasive infections14,15 . Both acute 
systemic Gram-positive and Gram-negative bacterial infections, as well as 
systemic fungal infections cause marked CRP rises, even in immunodeficient 
patients. By contrast, CRP concentrations tend to be lower in most acute viral 
infections. Nevertheless, this rule is not absolute and uncomplicated infections 
with adenovirus, measles, mumps and influenza are sometimes associated with 
high CRP levels. 
 
In addition to infection, there are several other conditions that commonly lead to 
substantial changes in CRP concentrations. These include trauma, surgery, 
burns, tissue necrosis, immunologically mediated inflammatory diseases, 
crystal-induced inflammatory diseases and advanced cancer. 
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CLINICAL APPLICATIONS OF C-REACTIVE PROTEIN 
 
A. Evaluation of a single C-reactive protein determination 
 
1. Sepsis diagnosis 
The value of a single CRP measurement in sepsis diagnosis has been 
investigated in different clinical situations. In two recently published studies in 
critically ill patients, the best cut-off for the diagnosis of sepsis was 50 mg/l 
(sensitivity 98.5% and specificity 75%) and 79 mg/l (sensitivity 71.8%, 
specificity 66.6%) 16,17 
 
2. Disease severity 
The single determinant of CRP level is its rate of synthesis, which in turn 
depends on the inflammatory insult intensity. In a recent study, CRP levels from 
each septic patient were grouped according to the ACCP/SCCM Consensus 
Conference classification . Mean values were 70 mg/l in systemic inflammatory 
response syndrome (SIRS) patients, 98 mg/l in sepsis, 145 mg/l in severe sepsis 
and 173 mg/l in septic shock, probably reflecting different degrees of 
inflammatory response 18. 
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3. Outcome prediction 
Besides its use in the diagnosis of sepsis, CRP has also been evaluated as a 
prognostic marker. Non-survivors had a median CRP concentration on 
admission of 70 mg/l, significantly higher than that measured in survivors (18 
mg/l)19 
 
B. Evaluation of serial c-reactive protein determinations 
 
There is a large body of literature dealing with clinical applications and the 
discriminative value of a single CRP value. However, it is more important to 
follow its evolution over the duration of hospital stay. Changes are very helpful 
in diagnosis as well as in monitoring response to therapy, as CRP levels are 
only determined by the rate of synthesis. In contrast, other acute phase 
phenomena such as leukocytosis and fever are dependent on complex 
mechanisms involving several mediators. Therefore, these markers are not 
reliable markers of sepsis. 
 
1. Sepsis diagnosis 
Infection should always be suspected if there is a steady increase in CRP levels 
over 2–3 days in the absence of an intervention likely to mount an inflammatory 
response. 
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2. Response to therapy 
After the diagnosis of infection and the start of therapy, serial determinations of 
CRP provide important information. The value of CRP changes over time has 
not yet been systematically investigated, but in several papers the authors 
recognised that decreases in CRP levels coincide with clinical improvements 
while, on the other hand, CRP increases suggest infectious complications.20,21 
 
In conclusion, serial CRP measurement, rather than a single determination at the 
time of admission, is a simple and valuable instrument in the diagnosis of sepsis 
and infection as well as in monitoring the response to therapy. 
 
Other markers of infection 
The classic markers of infection are fever and leukocytosis. Although 
economical and easy to measure, body temperature is a specific, but not 
sensitive, marker of infection22,23. The WCC count is routinely performed in 
almost every ICU and is also a criterion of sepsis. It is influenced by many non-
infectious factors, such as acute myocardial infarction, catecholamines, 
corticosteroids and acute bleeding.24 
 
PCT (Procalcitonin) was described more recently and is not routinely 
measured in all hospital laboratories. PCT levels have been shown to correlate 
with the severity of sepsis as measured by the acute physiology and chronic 
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health evaluation (APACHE) II or sequential organ failure assessment (SOFA) 
scores, and a recent meta-analysis reported that PCT was more sensitive and 
specific than CRP for differentiating bacterial from noninfective causes of 
inflammation. In addition, PCT is produced and cleared more rapidly than CRP, 
making it potentially more useful for identifying infection early and for 
following the progress of disease. Using a new sensitive and rapid PCT assay, 
Christ-Crain et al. have shown that PCT-guided therapy can reduce total 
antibiotic exposure and antibiotic treatment duration in patients with 
community-acquired pneumonia. However, further studies are needed to 
confirm these results and to evaluate the use of PCT levels to guide therapy in 
heterogeneous groups of patients. Further study is also needed to define and 
validate specific cut-off values in different disease states. 
 
Clinicians using PCT as a marker of infection should be aware of some 
important and potentially dangerous limitations. The behaviour of PCT in acute 
renal failure is still unknown . In cardiac surgery patients complicated with 
mediastinitis, PCT concentrations were almost normal (0.8±0.58 ng/ml) in 
comparison with noninfected patients (0.41±0.36 ng/ml)25. In a study in 
critically ill patients, PCT was below 1.0 ng/ml in 12.5% and 62.5% of infected 
patients with and without septic shock, respectively 26. Finally, in community-
acquired pneumonia PCT can be normal or even undetectable (median 0.2 
ng/ml, range 0.1–6.7 ng/ml, n=149) . There is no obvious explanation for these 
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unexpected findings. With regard to cost, measurement of PCT is considerably 
more expensive than CRP. 
 
Elevated serum levels of the intracellular enzyme LDH in sepsis might result 
from various mechanisms including cellular injury related to bacterial toxins, 
ischemia and cytotoxic-reactive oxygen species generated during reperfusion. 
Various studies have confirmed the presence of elevated LDH levels in severe 
sepsis. There is a study in US which predicted the development of ARDS in 
patients in sepsis based on serum LDH levels.27 
 
Prognostic Scoring Systems 
The high-complexity features of intensive care unit services and the clinical 
situation of  patients themselves render correct prognosis fundamentally 
important not only for patients, their families and physicians, but also for 
hospital administrators, fund-providers and controllers. Prognostic indices have 
been developed for estimating hospital mortality rates for patients hospitalised 
in intensive care units, based on demographic, physiological and clinical data. 
The most frequently used indices are APACHE II (Acute Physiology and 
Chronic Health Evaluation II), APACHE III (Acute Physiology And Chronic 
Health Evaluation III), SAPS II (Simplified Acute Physiology Score II) and 
MPM II (Mortality Probability Model II).32,33 
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The APACHE II index consists of a score that takes account of the patient’s 
age, chronic health condition and physiological variables (internal temperature, 
heart rate, respiratory rate, oxygenation, arterial pH, sodium, potassium, 
creatinine, hematocrit, white blood cells and Glasgow coma score). 
 
Markgraf et al.34 compared the predictive capabilities of APACHE II, APACHE 
III and SAPS II and concluded that the three indices have good discriminating 
power and that APACHE II has the best calibration. For this reason, it scored 
the most accurate mortality prediction. 
 
Over the past years many scoring models have been developed to describe the 
severity of illness of intensive care patients or to predict the outcome of 
intensive care. As an example, the first Sepsis-related Organ Failure Assessment 
score, later called the Sequential Organ Failure Assessment (SOFA) score, 
was introduced in 199435. The aim was to quantify the severity of the patients' 
illness based on the degree of organ dysfunction, serially over time. Although 
severity of illness scoring systems such as the Acute Physiology and Chronic 
Health Evaluation (APACHE) II and the Simplified Acute Physiology Score 
(SAPS)II 36are based on the first 24 hrs of intensive care unit (ICU) admission, 
the SOFA scoring system takes into account the time course of a patient's 
condition during the entire ICU stay. This enables physicians to follow the 
evolving disease process. The SOFA score is composed of scores from six 
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organ systems, each graded from 0 to 4 points according to the degree of 
dysfunction. The assignment of scores for each organ system is based on one or 
more variables. For example, the SOFA score for renal function is derived from 
the serum creatinine level and urine output. Previous studies have shown that 
the SOFA score is suitable to evaluate organ dysfunction. 
 
Vincent et al. 35stated that one of the criteria for a system that defines the degree 
of organ dysfunction is that it should be based on a limited number of simple 
but objective variables that are easily and routinely measured in every 
institution. With a total of 12 variables, the SOFA score contains fewer 
variables than most other ICU severity of illness scoring systems, such as 
APACHE II and SAPS II. 
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MATERIALS AND METHODS: 
The centre of study is Institute of Internal Medicine, Madras Medical College & 
Rajiv Gandhi Government General Hospital, Chennai – 3.  
Study Design         :        Cross sectional study. 
Venue                    :        Rajiv Gandhi Government General Hospital, Chennai 
 
Collaborating Departments :  
Institute of Biochemistry,  MMC&RGGGH, Ch-3 
Institute of Pathology ,  MMC&RGGGH, Ch-3 
Barnard Institute of Radiology, MMC&RGGGH,  Ch-3 
Institute of microbiology, MMC&RGGGH, Ch-3 
 
Duration        :  Study was conducted from June 2011 to  November  2011 
                                                                                    
About fifty patients who attended our outpatient  or emergency department with 
history of fever, cough with expectoration of recent onset, vomiting, burning 
micturition, breathlessness, confusion , or  jaundice were selected randomly. A 
complete history was taken either from the patient or his/ her attender including 
past history of jaundice, DM, hypertension, coronary artery disease, seizures, 
cva , COPD, h/o prior surgery, malignancy, blood transfusion and retroviral 
status. His/her personal habits were enquired. 
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A complete physical examination was done with monitoring of vitals 
(temperature, pulse rate, respiratory rate and blood pressure) everyday or 
frequently as the patient condition demanded.  A battery of blood investigations 
were done including renal functions, liver functions test, Complete blood count, 
HBs Ag, HIV, Widal test, MSAT, QBC for MP, blood –culture and sensitivity, 
serumCRP , sr LDH, prothrombin time and Arterial Blood gas analysis. Other 
investigations included were Urine analysis, urine – C/S, ECG, Chest X ray, 
USG abdomen and if required CT-Chest and CT- Abdomen. 
 
CBC, RFT and LFT were repeated on the third day (48-72 hrs) and APACHE-II 
score and SOFA score were computed on first and third day. 
 
C-reactive protein in serum was measured by Immunoturbidimetric Assay 
using clinical chemistry analysers. Lactate dehydrogenase- P was measured 
using kinetic DGKC method. 
 
Inclusion Criteria: 
Patients older than 18yrs of age admitted in medical ward with criteria for 
sepsis ,i.e., 
Two or more of the following conditions:  
1. fever (oral temperature >38°C) or hypothermia (<36°C); 
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2. tachypnea (>24 breaths/min); 
3. tachycardia (heart rate >90 beats/min); 
4. leukocytosis (>12,000/ L), leukopenia (<4,000/ L), or 
>10% bands;   plus   
proven or suspected microbial etiology 
 
Exclusion Criteria : 
1. Patients less than 18 years of age  
2. Patients with rheumatic heart disease and collagen vascular disease 
3. Patients with history of transient ischemic attack or cerebrovascular 
accident or coronary artery disease  
4. Patients with chronic kidney disease  
 
Statistical Analysis Plan :  
Data analysed using statistical package - SPSS Software 
 
Consent 
All participants / attenders gave written informed consent. 
 
Ethical Committee Approval 
Institutional  Ethics  Committee of Madras Medical College approved the study 
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OBSERVATION AND 
RESULTS 
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OBSERVATION AND RESULTS: 
 
In the study of fifty cases of sepsis admitted in Madras Medical College & Rajiv 
Gandhi Govt. General Hospital, Chennai, the following observations were made 
in sex incidence, age, Erythrocyte Sedimentation Rate, serum C-reactive protein 
level, serum Lactate dehydrogenase level, APACHE II score within 24hours of 
admission and after 48-72 hrs, SOFA score within 24hours of admission and 
after 48-72 hrs and prognosis of the illness as follows: 
 
Total number of patients     :   50 
Total number of males        :   27 (54%) 
Total number of females     :   23 (46%) 
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AGE INCIDENCE: 
 
Age incidence:     
Age Female Male Grand Total Percentage 
< 25 1 4 5 10% 
25 to 35 6 6 12 24% 
35 to 45 7 8 15 30% 
45 to 55 2 2 4 8% 
55 to 65 5 7 12 24% 
> 65 2 0 2 4% 
Grand Total 23 27 50  
 
Age average  =  43.52 
Age median   =  42.5 
Age mode      =  45 
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Age wise Distribution 
 
 
Mortality: Overall 
Total number of patients   :    50 
Total number - survived    :   37 
Total number - expired      :   13 
Mortality percentage          :   26% 
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           Females 
Total number of females  :  23 
Total number - survived  :   18 
Total number - expired    :    5 
Mortality percentage        :    21.7% 
             Males 
Total number of males     :    27 
Total number - survived  :    19 
Total number - expired    :     8 
Mortality percentage        :     29.5% 
 
 
0
2
4
6
8
10
12
14
16
18
20
F M
N
o
 O
f 
P
a
ti
e
n
ts
Sex group & Mortality
Expired
Survival
37 
 
 
Age wise Mortality: 
 
 
Age in yrs 
 
Expired 
 
Survival 
 
Grand Total 
 
Percentage 
< 25 1 4 5 20% 
25 to 35 3 9 12 25% 
35 to 45 2 13 15 13.3% 
45 to 55 1 3 4 25% 
55 to 65 5 7 12 41.6% 
> 65 1 1 2 50% 
Grand Total 13 37 50 26% 
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 Serum CRP, LDH and Mortality
Serum C-reactive protein, lactate dehydrogenase and ESR were done on 
admission and APACHE II and SOFA score were computed on day 1 (within 
24 hrs) and day 3 (48-72 hrs). 
<=10mg/dl and 40 patients had CRP le
CRP AND MORTALITY
CRP (mg/dl) Expired
<= 10 1 
> 10 12
Grand Total 13
 
 
 
Of the 13 death patients, only one had CRP < 10mg/dl while all others had CRP 
> 10mg/dl. 
8%
92%
Expired
 : 
out of the 50 patients, 10 patients had 
vel >10mg/dl. 
 
 Survival Grand Total Percentage
9 10 10%
 28 40 30%
 37 50 26%
 
<= 10
> 10
CRP
(mg/dl)
38 
CRP level 
 
 
 
 
 LDH AND MORTALITY:
 
LDH (IU/L) Expired
<1000 
>1000 
Grand Total 
 
 
Of the 13 death patients, only one had LDH <= 1000 IU/L while all others had 
LDH > 1000 IU/L. 
 
 
92%
 
 Survival Grand Total 
1 30 31 
12 7 19 
13 37 50 
 
8%
Expired
<1000 
>1000 
LDH 
(IU/L)
39 
Percentage 
3.22% 
63.15% 
26% 
 
 ESR AND MORTALITY :
 
ESR (mm/hr) Expired
<= 20 
20 to 40 
> 40 
Grand Total 
 
 
Of the 13 death patients, one had ESR <= 20mm/hr, eight had ESR between 20 
and 40 mm/hr and four had ESR > 
31%
 
 Survival Grand Total 
1 12 13 
8 21 29 
4 4 8 
13 37 50 
40mm/hr. 
8%
61%
Expired
<= 20
20 to 40
> 40
ESR 
(mm/hr)
40 
Percentage 
7.69% 
27.59% 
50% 
26% 
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Serum CRP, LDH and Prognosis: 
Before going into the analysis of serum CRP, LDH and ESR with prognosis, 
first we will look into the correlation between   CRP, LDH and ESR and 
smoking, alcohol, hypertension and diabetes mellitus.  
CRP vs Smoking 
 Smoking   
CRP (mg/dl) Yes No Grand Total 
<= 10 1 9 10 
> 10 8 32 40 
Grand Total 9 41 50 
 
p=0.66   NOT SIGNIFICANT 
The correlation between smoking  and CRP levels was not statistically 
significant. 
CRP vs Alcohol  
 Alcohol  
CRP (mg/dl) Yes No Grand Total 
<= 10 1 9 10 
> 10 7 33 40 
Grand Total 8 42 50 
 
p=0.08   NOT SIGNIFICANT 
The correlation between alcohol and CRP levels was not statistically 
significant. 
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CRP vs Hypertension 
 Hypertension   
CRP (mg/dl) Yes No Grand Total 
<= 10 0 10 10 
> 10 3 37 40 
Grand Total 3 47 50 
  
p=0.45   NOT SIGNIFICANT 
 
The correlation between hypertension and CRP levels was not statistically 
significant. 
 
CRP vs Diabetes mellitus 
 Diabetes mellitus   
CRP (mg/dl) Yes No Grand Total 
<= 10 3 7 10 
> 10 14 26 40 
Grand Total 17 33 50 
 
p=0.99  NOT SIGNIFICANT 
The correlation between Diabetes mellitus  and CRP levels was not statistically 
significant. 
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LDH vs Smoking 
 Smoking   
LDH (IU/L) Yes No Grand Total 
<1000 4 27 31 
>1000 5 14 19 
Grand Total 9 41 50 
 
p=0.28  NOT SIGNIFICANT 
The correlation between smoking and LDH levels was not statistically 
significant . 
 
LDH vs Alcohol 
 Alcohol   
LDH (IU/L) Yes No Grand Total 
<1000 5 26 31 
>1000 3 16 19 
Grand Total 8 42 50 
 
 p=1.00  NOT SIGNIFICANT 
 
The correlation between smoking and LDH levels was not statistically 
significant . 
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LDH vs Hypertension 
 Hypertension  
LDH (IU/L) Yes No Grand Total 
<1000 0 31 31 
>1000 3 16 19 
Grand Total 3 47 50 
 
P = 0.06 NOT SIGNIFICANT 
 
The correlation between hypertension  and LDH levels was not statistically 
significant. 
 
LDH vs Diabetes mellitus 
 Diabetes mellitus   
LDH (IU/L) Yes No Grand Total 
<1000 7 24 31 
>1000 10 9 19 
Grand Total 17 33 50 
 
P = 0.03 SIGNIFICANT 
The correlation between Diabetes mellitus  and LDH levels was  statistically 
significant. 
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ESR vs Smoking 
 Smoking   
ESR (min/hr) Yes No Grand Total 
<= 20 1 12 13 
20 to 40 7 22 29 
> 40 1 7 8 
Grand Total 9 41 50 
 
P = 0.41 NOT SIGNIFICANT 
 
The correlation between smoking and ESR values was not statistically 
significant. 
 
ESR vs Alcohol 
 Alcohol   
ESR (mm/hr) Yes No Grand Total 
<= 20 1 12 13 
20 to 40 6 23 29 
> 40 1 7 8 
Grand Total 8 42 50 
 
P = 0.61  NOT SIGNIFICANT 
 
The correlation between alcohol and ESR values was not statistically 
significant. 
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ESR vs Diabetes mellitus 
 Diabetes mellitus   
ESR (mm/hr) Yes No Grand Total 
<= 20 3 10 13 
20 to 40 12 17 29 
> 40 2 6 8 
Grand Total 17 33 50 
 
P = 0.45  NOT SIGNIFICANT 
The correlation between Diabetes mellitus  and ESR values was not statistically 
significant. 
ESR vs Hypertension 
 Hypertension   
ESR (mm/hr) Yes No Grand Total 
<= 20 0 13 13 
20 to 40 3 26 29 
> 40 0 8 8 
Grand Total 3 47 50 
 
P = 0.34  NOT SIGNIFICANT 
The correlation between hypertension  and ESR values was not statistically 
significant. 
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Comparison of  sr CRP and prognosis : 
Serum CRP on admission was compared with APACHE II score on admission 
and after 48 hours and also with SOFA score on admission and after 48 hours . 
The details are given below: 
CRP vs Apache II < 24 hrs 
 Apache II<24 hrs   
CRP (mg/dl) <=10 > 10 Grand Total 
<= 10 8 2 10 
> 10 14 26 40 
Grand Total 22 28 50 
 
P = 0.01 SIGNIFICANT  
 
 Correlation coefficient = 0.63 
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CRP vs Apaache II 48 - 72 hrs 
 
P = 0.01 SIGNIFICANT  
 
 
 
Correlation coefficient = 0.61 
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 Apache II 48-72hrs   
CRP <=10 > 10 Grand Total 
<= 10 9 1 10 
> 10 20 20 40 
Grand Total 29 21 50 
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CRP vs Sofa < 24 hrs 
 SOFA < 24hrs   
CRP(mg/dl) <=7 >7 Grand Total 
<= 10 9 1 10 
> 10 27 13 40 
Grand Total 36 14 50 
 
P = 0.07 NOT SIGNIFICANT  
 
 
Correlation coefficient =  0.45 
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CRP vs Sofa 48- 72 hrs 
 SOFA 48-72hrs   
CRP(mg/dl) <=7 >7 Grand Total 
<= 10 9 1 10 
> 10 27 13 40 
Grand Total 36 14 50 
 
P = 0.07 NOT SIGNIFICANT  
 
 
 
Correlation coefficient = 0.59  
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Comparison of  sr LDH and prognosis : 
Serum LDH on admission was compared with APACHE II score on admission 
and after 48 hours and also with SOFA score on admission and after 48 hours . 
The details are as follows: 
LDH vs APACHE II < 24 hrs 
 Apache II <24hrs   
LDH (IU/L) <=10 > 10 Grand Total 
<1000 19 12 31 
>1000 3 16 19 
Grand Total 22 28 50 
 
P = 0.003  SIGNIFICANT 
 
Correlation coefficient = 0.58 
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LDH vs APACHE II 48 - 72 hrs 
 
P = 0.001  SIGNIFICANT 
 
 
Correlation coefficient = 0.73 
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Grand Total 29 21 50 
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LDH vs Sofa < 24 hrs 
 
P = 0.002  SIGNIFICANT 
 
 
Correlation coefficient = 0.59  
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LDH vs Sofa 48 - 72 hrs 
 SOFA 48-72hrs   
LDH (IU/L) <=7 >7 Grand Total 
<1000 30 1 31 
>1000 6 13 19 
Grand Total 36 14 50 
 
P = 0.00001  SIGNIFICANT 
 
 
 
Correlation coefficient = 0.71  
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ESR vs APACHE II < 24hrs 
 
P = 0.07  NOT SIGNIFICANT 
 
 
Correlation coefficient = 0.39  
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ESR vs APACHE II 48-72 hrs 
 
P = 0.99  NOT SIGNIFICANT 
 
 
Correlation coefficient = 0.29  
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ESR vs SOFA <24 hrs 
 
P = 0.48  NOT SIGNIFICANT 
 
 
Correlation coefficient = 0.45  
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ESR vs SOFA 48-72 hrs 
 
P = 0.42  NOT SIGNIFICANT 
 
 
Correlation coefficient = 0.33 
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CC =  Correlation coefficient 
          
 APACHE II 
<24HRS 
APACHE II 
48-72 HRS 
SOFA 
<24HRS 
SOFA 
48-72 HRS 
ESR 
(mm/hr) 
P =0.07 P =0.99 P =0.48 P =0.42 
 
CC =0.39 
 
CC =0.29 CC =0.45 CC =0.33 
CRP (mg/dl) P =0.01 
 
P =0.01 P =0.07 P =0.07 
 
CC =0.63 
 
CC =0.61 CC =0.45 CC =0.59 
LDH (IU/L) P =0.03 
 
P =0.001 P =0.002 P =0.00001 
 
CC =0.58 
 
CC =0.73 CC =0.59 CC =0.71 
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 Sensitivity, Specificity and Positive Predictive Value Estimation for  
 sr CRP :                     
 
Sensitivity =  TP/(TP + FN) * 100 
                  =  26/28 * 100 
                  = 92.85% 
Specificity =  TN/(TN+FP) * 100 
                  = 36.36% 
PPV     = TP/(TP+FP) * 100 
            = 65% 
NPV    = TN/ (TN+ FN )* 100 
            = 80% 
 
 
CRP (mg/dl) 
 
ApacheII <24 hrs >10 
 
ApacheII <24 hrs <=10 
 
Grand Total 
> 10 26 14 40 
<= 10 2 8 10 
Grand Total 28 22 50 
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Sensitivity, Specificity and Positive Predictive Value Estimation 
for sr LDH:   
 Apache II<24hrs   
LDH (IU/L) > 10 <=10 Grand Total 
>1000 16 3 19 
<1000 12 19 31 
Grand Total 28 22 50 
              
Sensitivity =  TP/(TP + FN) * 100 
                  =  16/28 * 100 
                  = 57.14% 
Specificity = TN/(TN+FP) * 100 
                  =  86.36% 
PPV = TP/(TP+FP) * 100 
        = 84.21% 
 
NPV = TN/ (TN+ FN) * 100 
         = 19/31 * 100 
         = 61.29% 
When combining sr CRP <= 10mg/dl and sr LDH <=1000 IU/L , negative 
predictive value of the test for prognosis is 100%. 
 
When combining sr CRP > 10mg/dl and sr LDH >1000 IU/L , positive 
predictive value of the test for prognosis is 87.5%. 
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DISCUSSION 
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DISCUSSION: 
CRP is a marker of inflammation that has been used to monitor the course of 
infection and inflammatory diseases. Recently, CRP has been seen not only as a 
biochemical marker of inflammation but also as an active modulator of the 
inflammatory response. In this context, we evaluated the correlation of CRP 
and LDH levels with organ failure and mortality early after admission in a 
heterogeneous group of patients. We found that increased CRP concentrations 
were associated with organ failure, prolonged intensive care  and high infection 
and mortality rates. CRP concentrations > 10 mg/dL  and LDH >1000 IU/L on  
admission were associated with a particularly high mortality. 
 
Evaluating changes in variables over time may be very helpful to assess the 
effects of interventions, as has been shown for organ dysfunction scoring 
systems. Lopes Ferreira et al28  reported that an increase in SOFA score during 
the first 48 hours in the ICU predicts a mortality rate of at least 50%, while a 
decreasing SOFA score is associated with a decrease in mortality rates from 50 
to 27%. In patients with sepsis, Presterl et al29 demonstrated a correlation 
between the plasma levels of CRP, IL-6 and tumor necrosis factor-sR, and the 
APACHE III and mortality probability model II scores. Both scoring systems, 
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as well as CRP levels, were significantly higher in the nonsurvivors compared 
with the survivors. Nonsurvivors had significantly higher CRP levels from day 
3 onwards. Our findings on the relation between the concentrations of CRP and 
APACHE II and SOFA scores indicate that both these parameters are useful 
indicators of severity and prognosis.  
 
 
Bonig et al30 reported that CRP levels > 10 mg/dL were predictive of poor 
outcome after hematopoietic stem cell transplantation in children. Chronic 
inflammation plays a role in the pathogenesis of cardiovascular diseases and 
elevated serum levels of CRP are associated with an increased risk of 
myocardial infarction and sudden cardiac death in apparently healthy subjects.  
Zimmermann et al 31 reported that high CRP levels in hemodialysis patients 
were closely related to high levels of vascular atherogenic risk factors and 
cardiovascular deaths. Serum concentrations of CRP and IL-6 have been shown 
to be inversely related to renal function in the predialytic phase of renal failure. 
In the present study, high CRP levels and high LDH levels at admission were 
associated with more days of receiving extracorporeal support. 
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In our study, the overall mortality was 26% .The mortality rate in males was 
29.5% and in females was 21.7%. The mortality rate increased with increasing 
age and it was 41.6% in patients with age group 55-65 years and 50% in 
patients with age >65 years of age.  
 
Comparison of Age, CRP, LDH, Apache II and Sofa scores between 
expired and survived patients 
 
 Expired Survived 
No of Patients 13 37 
Age 47.07 42.27 
CRP 25.98  +  11.64 13.77  +  5.64* 
LDH 1591  +  601.5 691.4  +  359.54* 
Apache II<24 hrs 18.38  +  3.4 10.16  +  3.59* 
Sofa <24 hrs 10  +  2.86 4.54  +  2.28* 
 
*P <0.05 (T test)  
 
The mortality rate in patients with serum CRP > 10 mg/dl was 30% while the 
mortality rate in patients with serum CRP < 10 mg/dl was 10%. The patients 
with serum CRP > 10 mg/dl also had prolonged hospital stay and multiple organ 
dysfunctions.  
 
In our study, the number of patients with serum CRP < 10 mg/dl was 10 and 
with serum CRP > 10 mg/dl was 40. In the srCRP < 10 mg/dl group, the mean 
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ApacheII score on admission was 8.3 and after 48 hours was 6.55. The mean 
SOFA score on admission was 4.3 and after 48 hours was 3. In the srCRP > 10 
mg/dl group, the mean ApacheII score on admission was 13.3 and after 48 
hours was 11.64. The mean SOFA score on admission was 6.4 and after 48 
hours was 5.57.This is consistent with other studies which used serum CRP as a 
prognostic marker in sepsis such as  
Lopez et al,2011 37 
Castelli et al ,200438 
Loboet al,2003 39 
 
Comparison of Age, Apache II and Sofa scores between the two CRP 
groups 
 
 
       CRP <= 10 mg/dl               CRP > 10 mg/dl 
No of Patients 10 40 
Age 42.5 43.775 
Apache II<24 hrs 8.3  + 3.34 13.3  +  4.79* 
Apache II 48 - 72 hrs 6.55  +  2.35 11.64 +  5 .86* 
SOFA < 24 hrs 4.2  +  2.94 6.4  +   3.52 
SOFA 48 -72 hrs               3 +  1.66              5.57+  3.39* 
 
*P <0.05 (T test)  
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The mortality rate in patients with serum LDH > 1000 IU/L was 63.15% while 
the mortality rate in patients with serum LDH < 1000 IU/L was 3.22%. The 
patients with serum LDH > 1000 IU/L also had prolonged hospital stay and 
multiple organ dysfunctions as evident from SOFA score.  
In our study, the number of patients with serum LDH < 1000 IU/L was 31 and 
with serum LDH > 1000 IU/L was 19. In the sr LDH < 1000 IU/L group, the 
mean ApacheII score on admission was 8.3 and after 48 hours was 6.55. The 
mean SOFA score on admission was 4.3 and after 48 hours was 3. In the srLDH 
> 1000 IU/L group, the mean ApacheII score on admission was 13.3 and after 
48 hours was 11.64. The mean SOFA score on admission was 6.4 and after 48 
hours was 5.57.This is consistent with other studies which used serum LDH as a 
prognostic marker in sepsis such as  
J.G. Zein et al, 2004 40 
Comparison of Age, Apache II and Sofa scores between the two LDH 
groups 
 LDH <= 1000IU/L LDH > 1000IU/L 
No of Patients 31 19 
Age 43.58 43.4 
Apache II <24 hrs 10.19 +  3.6 15.73  +  5.28* 
Apache II 48 - 72 hrs 8.13  +  3.3 15.37  +  5.8* 
SOFA < 24 hrs 4.51  +  2.57 8.3  +  3.36* 
SOFA 48 -72 hrs 3.4  +  1.75 7.5  +  3.61* 
 
*P <0.05 (T test)   
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The study showed significant correlation between serum Lactate dehydrogenase 
and diabetes mellitus which has been seen in studies such as “ Activity of blood 
serum lactate dehydrogenase in diabetes mellitus” 1977 May-Jun;23(3):15-7.41 
 
 
Serum CRP levels correlated well with the APACHE II score at admission and 
after 48 hours but had poor correlation with SOFA score. On the other hand, 
serum LDH had good correlation with both APACHE II score and SOFA score 
at admission and after 48 hours. However, further studies are required to 
confirm or repute these findings.  
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LIMITATIONS OF STUDY 
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LIMITATIONS OF STUDY: 
 
 
1. We found that in our study there were some limitations with the sample 
size which precluded us from getting statistical significance with regard 
to certain variables with the severity of sepsis. 
 
2. In our study, serum CRP and LDH levels were measured at the time of 
presentation and were not measured serially due to financial constraints 
and hence could not follow its evolution over the duration of hospital 
stay. Changes are very helpful in diagnosis as well as in monitoring 
response to therapy, as CRP levels are only determined by the rate of 
synthesis. 
 
3. We had some confounding effect of Diabetes mellitus on serum Lactate 
dehydrogenase values which could not be corrected. 
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CONCLUSION 
 
72 
 
CONCLUSION : 
1. Determination of CRP is an economical, consistent and reproducible test 
and is available in almost every hospital. 
 
2. Serum CRP has been found to be significantly elevated with increasing 
severity of SEPSIS which could lead to increased predisposition to 
morbidity and mortality. 
 
3. Serum Lactate Dehydrogenase level has been found to be significantly  
elevated with increasing severity of SEPSIS which could lead to 
increased predisposition to morbidity and mortality. Further studies are 
needed. 
 
4. ESR is not a good prognostic marker for sepsis. 
 
5. Combining srLDH and srCRP values has better positive value and 
negative predictive value than either of the two when used individually. 
 
6. Mortality of sepsis increases with the age of the patient . 
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SERUM LACTATE DEHYDROGENASE AND C REACTIVE 
PROTEIN LEVEL IN SEPSIS AND ITS CORRELATION 
WITH APACHE-II SCORE 
 
PROFORMA 
 
S. No. 
 
Name :                                                           Age:                             Sex: 
 
Occupation: 
 
 
Contact No.: 
 
 
Hospital No.: 
 
 
Symptoms: 
 Fever 
 Cough with expectoration 
 Jaundice 
 Vomiting 
 Breathlessness 
 Burning  micturation 
 Seizures  
 Altered sensorium 
 Bleeding tendencies 
 
 
PAST HISTORY 
 Jaundice 
 Surgery 
 Blood transfusion 
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 Diabetes mellitus  
 Hypertension  
 Chronic liver disease  
 Malignancy 
 Retroviral status  
 
v) PERSONAL HISTORY 
 Alcohol 
 Smoking 
 Drug abuse 
 Marital Status 
 Promiscuity 
 
EXAMINATION 
Signs: 
Consciousness :                                                  Orientation : 
 
Clubbing : 
Pallor : Y/ N                                                       Cyanosis : 
Jaundice : Y / N                                                  Pedal edema : 
Lymphadenopathy :                                            JVP : 
  
Skin – petechia or purpura : Y / N                                                   
Vital signs : 
Temperature  :                                                     
Respiratory rate: 
Pulse : 
Blood pressure: 
 
Systemic examination : 
 
CVS : 
 
RESPIRATORY SYSTEM: 
 
ABDOMEN : 
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CNS: 
 
GCS: 
Neck stiffness: Y/N 
 
INVESTIGATIONS 
1. Complete Hemogram 
           Hb%                                                      Platelets 
           TC                                                         ESR 
           DC                                                         Hematocrit 
 
2. Urine analysis 
 
3. Blood sugar 
 
4 Serum creatinine                                Blood urea 
   Urine output 
5. Serum Na                                           Serum K 
6. Liver function tests 
            T. Bilirubin :                                          SAP : 
            D. Bilirubin :                                          T. Protein : 
            ID. Bilirubin :                                         Albumin : 
            AST :                                                        
            ALT :  
7. PT / INR : 
8. ECG 
9. X- ray chest  
10.Blood C/S 
11.Urine C/S (if necessary) 
12. Sputum C/S 
13. MSAT                         WIDAL                                  QBC for MP 
14. Ultrasound abdomen  
15. CT Chest if necessary 
16. Arterial blood gas analysis 
17. PaO2 
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18. CRP level                      LDH level  
19. HbsAg                          AntiHCV antibodies        
 
  
 
 
 
 
Day 0                  Day2 
85 
 
 
 
Sepsis-related organ failure assessment (SOFA) score.  
 
 
Organ system                                          Measure 
Respiration                                               PaO2 to FiO2 ratio 
Coagulation                                              Platelet count 
Liver                                                         Serum bilirubin 
Cardiovascular                                         Hypotension 
Central nervous system                            Glasgow coma score 
Renal                                                        Serum creatinine or                                    
                          urine output 
 
 
Measure                                     Finding                                      Points    Day0   Day2 
 
PaO2 to FiO2 ratio                         >400 (mmHg)                                               0 
                                                          300–399 (mmHg)                                          1 
                                                          200–299 (mmHg)                                          2 
                                                          100–199 (mmHg)                                          3 
                                                     <100 (mmHg)                                               4 
 
Platelet count                                      1500/ml                                             0                    
                                                            1000–149 999/ml                              1                   
                                                            500–99 999/ml                                  2                      
                                                            200–49 999/ml                                  3                     
                                                      <200 per ml                                      4                     
 
Serum bilirubin                                   <1.2 mg/dl                                        0 
                                                             1.2–1.9 mg/dl                                   1 
                                                             2.0–5.9 mg/dl                                   2 
                                                             6.0–11.9 mg/dl                                 3 
                                                       12.0 mg/dl                                        4 
 
Hypotension                         Mean arterial pressure _ 70 (mmHg)              0 
                                              Mean arterial pressure <70 then (no pressor 
                                                            agents used) (mmHg)                        1 
          Dobutamine any dose              2 
          Dopamine _ 5 mg/kg per min              2 
          Dopamine >5–15 mg/kg per min             3 
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          Dopamine >15 mg/kg per min             4 
          Adrenaline _ 0.1 mg/kg per min             3 
          Adrenaline >0.1 mg/kg per min             4 
          Noradrenaline _ 0.1 mg/kg per min             3 
          Noradrenaline >0.1 mg/kg per min             4 
 
Glasgow coma score            15                 0 
          13–14                            1 
          10–12                            2 
          6–9                            3  
          3–5                            4 
 
Serum creatinine or 
urine output 
          Serum creatinine <1.2 mg/dl              0 
          Serum creatinine 1.2–1.9 mg/dl             1 
          Serum creatinine 2.0–3.4 mg/dl                       2 
          Serum creatinine 3.5–4.9 mg/dl             3 
          Urine output 200–499 ml/day              3 
          Serum creatinine >5.0 mg/dl              4 
          Urine output <200 ml/day              4 
 
 
PaO2 is in mmHg and FiO2 in per cent, from 0.21 to 1.00. 
Adrenergic agents as administered for at least 1 hour with doses in mg/kg per min. 
A score of 0 indicates normal and a score of 4 indicates most abnormal. 
Data can be collected and the score calculated daily during the course of the admission. 
Interpretation: minimum total score: 0; maximum total score: 24. 
The higher the organ score, the greater the organ dysfunction. 
The higher the total score, the greater the multiorgan dysfunction. 
 
 
 
 
Mortality rate by SOFA score. 
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1 Pakkiri 55 M 10.2 522 28 80,000 14 9 6 
2 Paleesan  42 M 25.8 340 5 1,56,000 12 7 6 
3 Karthick 21 M 1.1 240 120 1,14,000 42 18 * 
4 Rajasekar 65 M 17.16 420 36 2,18,000 20 11 14 
5 Kumaresan 26 M 7.9 1110 27 68,000 15 3 2 
6 Saroja 35 F 11.92 320 40 70,000 23 9 7 
7 Mohammed Basha  40 M 29.58 450 36 1,96,000 20 15 7 
8 Rajasekar 30 M 11 393 26 2,32,000 13 6 2 
9 Niranjan 28 M 18.5 196 42 1,72,000 15 16 9 
10 Palani 34 M 38.6 1420 50 1,40,000 18 26 23 
11 egavalli 27 F 18.78 1418 31 1,60,000 14 16 * 
12 Kumar 36 M 36.58 2540 40 1,20,000 13 24 * 
13 Kavitha 29 F 8.7 430 20 1,90,000 26 5 5 
14 suresh 28 M 45.3 2344 45 2,56,000 16 14 17 
15 Kamatchi 45 F 14 650 25 1,80,000 16 8 5 
16 Kuppammal 30 F 24 1200 40 1,67,000 19 14 10 
17 subramani 53 M 37 2100 26 1,10,000 23 18 20 
18 Mary 58 F 24.6 480 45 2,10,000 19 10 6 
19 Saroja 63 F 14.3 690 30 1,30,000 15 8 5 
20 kamala 26 F 18.2 550 22 87,000 21 8 6 
21 Raji 46 F 23.12 1800 40 1,45,000 26 16 18 
22 mani 63 M 7.9 460 24 1,90,000 17 8 6 
23 Ponnammal 60 F 22.8 1690 45 1,70,000 22 21 * 
24 Elumalai 24 M 12 870 23 1,45,000 14 6 8 
25 Perumal 65 M 30.5 1200 20 3,09,000 20 18 17 
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1 Pakkiri 5 4 Y Y N N Rt LL pneumonia Survival 
2 Paleesan  0 1 N N N N UTI Survival 
3 Karthick 12 * N N N N ALF Expired 
4 Rajasekar 3 2 N Y N N Rt UL pneumonia Survival 
5 Kumaresan 3 0 Y N N N Pneumonia Survival 
6 Saroja 2 2 N N N N UTI Survival 
7 Mohammed 
Basha  
6 3 Y Y N N Rt ML pneumonia Survival 
8 Rajasekar 2 1 Y Y N N Lt LL pneumonia Survival 
9 Niranjan 7 5 N N N N B/L 
Bronchopneumonia 
Survival 
10 Palani 14 14 Y Y N N Lt LL pneumonia Expired 
11 egavalli 10 * N N N N B/L 
Bronchopneumonia 
Expired 
12 Kumar 15 * Y Y N N ARDS Expired 
13 Kavitha 3 2 N N N N B/L 
Bronchopneumonia 
Survival 
14 suresh 6 7 N N N N Lepto/ ARDS Expired 
15 Kamatchi 2 1 N N N Y UTI Survival 
16 Kuppammal 6 4 N N N N Rt LL pneumonia Survival 
17 subramani 9 12 N N Y Y Rt LL pneumonia Expired 
18 Mary 4 4 N N N Y Rt LL cellulitis Survival 
19 Saroja 4 3 N N N N Lt UL pnemonia Survival 
20 kamala 5 5 N N N N UTI Survival 
21 Raji 7 9 N N N Y B/L 
Bronchopneumonia 
Survival 
22 mani 2 1 N N N N Lt LL pneumonia Survival 
23 Ponnammal 13 * N N N Y B/L pneumonia Expired 
24 Elumalai 3 3 N N N N UTI Survival 
25 Perumal 7 9 N N N Y Rt renal abscess Expired 
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26 Venda 43 F 12.8 250 20 2,30,000 16 10 8 
27 Chinnaiya 45 M 16 620 18 1,80,000 19 12 7 
28 Siva 34 M 6 300 12 70,000 16 6 6 
29 Mathialagan 63 M 18 1590 40 1,90,000 28 16 18 
30 Ganapathy 38 M 12 457 16 2,87,000 19 6 6 
31 Selvaraj 62 M 14 870 20 1,85,000 14 12 15 
32 Kalyani 67 F 23 1200 26 2,20,000 22 18 20 
33 Maheshwari 56 F 8.3 680 30 1,30,000 14 6 7 
34 Angel 35 F 7.12 430 16 1,98,000 16 8 8 
35 Kumari 48 F 12.9 980 23 3,45,000 26 14 12 
36 Mahesh 25 M 11.8 1100 24 2,10,000 20 14 9 
37 Kanagammal 45 F 17 1200 26 2,15,000 20 16 18 
38 Sundaram 65 M 13.7 650 20 2,30,000 23 16 16 
39 Francis  43 M 15 450 15 3,68,000 12 17 13 
40 Kamal 24 M 14 1400 36 1,45,000 15 14 16 
41 Kodandam 56 M 24 2100 40 56,000 24 18 22 
42 Kamala 38 F 14.26 710 22 80,000 14 12 10 
43 Sugumari 72 F 9.7 328 29 68,000 32 12 10 
44 Veerammal 38 F 11.7 850 23 3,90,000 16 10 9 
45 Sahul 42 M 12.8 920 18 2,30,000 21 13 12 
46 James 45 M 7.45 1200 26 4,80,000 14 9 9 
47 subbammal 57 F 25.1 1650 24 1,10,000 17 16 18 
48 Sivagami 24 F 12 870 42 2,00,000 22 10 7 
49 Malliga 44 F 6.9 530 20 3,12,000 18 8 6 
50 Rajeshwari 38 F 12 1100 45 2,38,000 26 8 9 
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26 Venda 4 2 N N N N Rt LL pneumonia Survival 
27 Chinnaiya 7 6 N N N N UTI Survival 
28 Siva 3 2 N Y N N Rt UL pneumonia Survival 
29 Mathialagan 8 8 Y Y N Y B/L pneumonia Expired 
30 Ganapathy 1 2 Y N N N Lt LL pneumonia Survival 
31 Selvaraj 6 3 N N N Y Lt UL pnemonia Survival 
32 Kalyani 10 11 N N Y Y Rt Psoas abscess Expired 
33 Maheshwari 3 4 N N N Y UTI Survival 
34 Angel 3 2 N N N N Rt LL pneumonia Survival 
35 Kumari 8 6 N N N Y Rt LL cellulitis Survival 
36 Mahesh 6 5 N N N N Rt LL pneumonia Survival 
37 Kanagammal 11 12 N N Y Y Rt LL pneumonia Expired 
38 Sundaram 9 7 N N N Y Rt UL pneumonia Survival 
39 Francis  5 2 N N N N Rt UL pneumonia Survival 
40 Kamal 10 8 N N N N Sepsis/ ARDS Survival 
41 Kodandam 8 9 Y N N Y B/L pneumonia Expired 
42 Kamala 3 4 N N N N Rt ML pneumonia Survival 
43 Sugumari 6 4 N N N Y Rt pyelonephritis Survival 
44 Veerammal 6 6 N N N N UTI Survival 
45 Sahul 8 6 N N N N Lt UL pnemonia Survival 
46 James 3 4 N N N Y Rt Psoas abscess Survival 
47 subbammal 7 9 N N N Y Rt LL pneumonia Expired 
48 Sivagami 4 4 N N N N Rt LL pneumonia Survival 
49 Malliga 4 5 N N N N UTI Survival 
50 Rajeshwari 5 5 N N N N Lt UL pnemonia Survival 
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